Understanding the Thyroid and Gut-Hormone Integration Concepts

Discover the links between thyroid function and gut health through insights into hormone integration in the body.

Abstract

This educational post explores modern, evidence-based insights into thyroid physiology, with an emphasis on free T3, free T4, and the limitations of TSH as a sole marker. I present why many people with “normal” thyroid labs still experience hypothyroid symptoms and how gut health, stress, medications, and insulin resistance disrupt deiodinase activity and T4-to-T3 conversion. I also outline our integrative model in El Paso, Texas, where Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933) serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic). Together, we integrate chiropractic care, internal medicine oversight, functional medicine, personal injury care, and rehabilitation to optimize thyroid and whole-body outcomes. This guide provides clinical reasoning, physiological underpinnings, and practical protocols, including testing strategies and gut-hormone alignment methods, supported by current peer-reviewed research and clinical observations from my practice.

Introduction: Reframing Thyroid Care Through an Integrative Lens

As a chiropractor and advanced practice nurse with board certification in family practice and functional medicine, I have seen the same recurring problem: patients told their thyroid is “normal” based on a TSH value, yet they feel cold, fatigued, foggy, depressed, constipated, and unable to lose weight. When we look deeper—specifically at free T3, free T4, and thyroid antibodies—we often find impaired conversion and immune activation that TSH alone cannot capture. This is not a niche issue; it reflects a system-wide gap in the evaluation and treatment of thyroid dysfunction.

At our El Paso multidisciplinary clinic, I work closely with Dr. Maria Guadalupe Cardenas, MD, who provides medical direction, diagnostic collaboration, and pharmacologic oversight. Under her guidance, our team aligns integrative chiropractic care with internal medicine, functional medicine, rehabilitation, and personal injury care. This multidisciplinary synergy ensures that physiological insights translate into practical, personalized care.

Below, I walk you through the physiology, research, and clinical strategies that inform our approach, and I explain how gut health sits at the crossroads of thyroid conversion and systemic hormone balance.

Why TSH Alone Is Not Enough

• Key idea: TSH is a pituitary signal, not a direct measure of circulating thyroid hormones in tissues. It is useful for population-level screening but limited for nuanced clinical management.
• Physiological context:

• • TSH reflects pituitary sensing of circulating thyroid hormone levels via feedback loops.
  • Free T4 (FT4) is the principal secretory product of the thyroid; it is a prohormone.
  • Free T3 (FT3) is the active hormone at nuclear thyroid receptors, modulating transcription of genes involved in metabolism, thermogenesis, cardiac function, and neurocognition.
  • Most T3 is generated peripherally from T4 via deiodinase enzymes (D1 and D2), rather than being secreted directly by the thyroid.

• Clinical limitation:

• • Patients can have “normal” TSH with low FT3 due to impaired conversion, leading to hypothyroid symptoms despite conventional “normal” labs.
  • TSH fluctuates diurnally and is influenced by age, illness, and medications, making it suboptimal for titrating therapy after treatment initiation (Garber et al., 2012).

In my practice, focusing on FT3, FT4, and symptom complexes has improved detection of conversion problems. I consider TSH but do not anchor decisions solely on it when symptoms and FT3/FT4 point toward dysfunction.

Deiodinase Physiology: The Conversion Bottleneck

• Key idea: Deiodinase enzymes (D1, D2) convert T4 to T3. Their activity is easily disrupted.
• Disruptors of deiodinase function:

• • Stress and elevated cortisol: Shifts conversion toward inactive reverse T3 (rT3), reducing FT3 availability (Fliers et al., 2014).
  • Gut dysbiosis and intestinal permeability: Inflammation and endotoxemia alter hepatic and intestinal deiodinases (Peeters et al., 2003).
  • Insulin resistance: Common in modern populations, IR impairs cellular signaling and thyroid hormone activation, increasing rT3 (Ghasemi et al., 2019).
  • Medications: Beta-blockers, glucocorticoids, amiodarone, lithium, and certain statins and oral contraceptives can blunt conversion or affect binding proteins (Weetman, 2013; Bianco & Kim, 2006).
  • Aging: Age-related changes reduce deiodinase activity and increase binding proteins, lowering FT3 availability despite normal TSH (Gerritsen et al., 2020).

• Physiological consequences:

• • Low FT3 leads to decreased mitochondrial function, reduced basal metabolic rate, impaired lipid clearance, and altered cardiac contractility and mood regulation (Gereben et al., 2008).

When deiodinase activity drops, patients often present with a normal TSH, normal or mid-range FT4, low-normal or low FT3, and elevated rT3, while describing classic hypothyroid symptoms. This is one of the most common patterns I see in clinic.

How Gut Health Drives Thyroid Conversion and Hormone Balance

• Key idea: The gut-liver axis is central to thyroid conversion and systemic hormone metabolism.
• Mechanisms:

• • The intestinal microbiome regulates bile acids and hepatic pathways essential for T4-to-T3 conversion (Gérard, 2016).
  • Lipopolysaccharide (LPS) from dysbiosis triggers systemic inflammation, raising cortisol and shifting T4 to rT3 (Fliers et al., 2014).
  • Gut dysbiosis impairs estrogen metabolism via altered β-glucuronidase activity, contributing to estrogen dominance, fibroids, and hormone-driven cancers (Plottel & Blaser, 2011).
  • Poor gut health elevates insulin and leptin, further impairing thyroid activation (Ghasemi et al., 2019).

• Clinical phenotype:

• • Low FT3, high rT3, high cortisol in saliva/urine, insulin resistance on HOMA-IR, low testosterone/progesterone, poor sleep, and postprandial fatigue—often with bloating, reflux, constipation, or loose stools.

In short, the gut is the hormone engine: when it fails, thyroid conversion collapses, and multi-hormone dysfunction emerges. I frequently see this constellation in personal injury patients and chronic pain cases, where stress, disrupted sleep, and medications exacerbate dysbiosis and hormonal imbalance.

Clinical Testing: Beyond TSH

• Testing strategy:

• • TSH, Free T4, Free T3, Reverse T3.
  • Thyroid antibodies: TPO and TgAb to detect autoimmune activation (e.g., Hashimoto’s thyroiditis).
  • Cortisol: Diurnal saliva or urinary metabolites; assess stress axis.
  • Insulin resistance: Fasting insulin, glucose, HOMA-IR, lipid panel with triglycerides/HDL ratio.
  • Gut function: Stool analysis for microbiome composition, inflammation markers (calprotectin), digestive markers, and dysbiosis; consider SIBO breath testing when indicated.
  • Sex hormones: Estradiol, progesterone, testosterone, DHEA, SHBG; sometimes DUTCH urine metabolites to evaluate estrogen processing and androgen pathways.

• Why this combination:

• • It connects root causes (gut, stress, IR, autoimmunity) to thyroid expression at the tissue level.
  • Correlating symptom clusters with FT3/FT4 and rT3 informs whether conversion or production is the primary issue.

The goal is to map a patient’s physiology rather than chase a single lab number.

Evidence-Based Ranges and Outcomes: Why FT3 Optimization Matters

• Reference ranges:

• • Standard lab ranges are based on large populations, often including individuals with suboptimal health. Being “in-range” may not equate to optimal tissue function (Surks et al., 2004).

• Clinical evidence:

• • Lower FT3 is associated with higher all-cause mortality, increased cardiovascular risk, and adverse metabolic profiles (Iervasi et al., 2003; Jabbar et al., 2017).
  • Optimizing FT3 within the upper half of the normal range is linked to improved metabolic function, mood, and energy, without overt hyperthyroidism when titrated carefully (Bianco et al., 2019).

• Rationale:

• • FT3 drives mitochondrial biogenesis and thermogenesis; modest upward optimization often restores physiologic vigor, particularly in patients with conversion defects and persistent symptoms.

In practice, we do not chase numbers mindlessly; we titrate to symptom relief and functional gains while monitoring heart rate, blood pressure, bone markers, and labs to avoid overtreatment.

Integrative Chiropractic Care Within a Medical-Functional Framework

• Team model:

• • Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933) serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas.
  • I provide integrative chiropractic care, functional medicine assessments, and rehabilitation strategies.

• How we work together:

• • Medical oversight ensures safe pharmacologic management, imaging, and diagnostics. Dr. Cardenas evaluates comorbidities, medication interactions, and cardiovascular risk.
  • Chiropractic care addresses biomechanical dysfunction, pain, and autonomic regulation. Adjustments and soft-tissue techniques can modulate sympathetic tone, reduce pain-mediated stress, and improve vagal activity, facilitating better gut motility and hormone signaling.
  • Functional medicine connects biochemical imbalances with lifestyle and environmental triggers. We use precision nutrition, supplement protocols, sleep regulation, and stress-modulation techniques.
  • Rehabilitation and personal injury care integrate movement-based therapies, graded exercise, and brain-body techniques to restore resilience and reduce inflammation.

• Why chiropractic matters here:

• • Chronic pain and spinal dysfunction elevate sympathetic output, raising cortisol and impairing thyroid conversion.
  • Manual therapies can improve proprioception, reduce nociceptive input, and enhance heart rate variability (HRV)—a marker of autonomic balance—supporting endocrine recovery (Martínez-Rodríguez et al., 2021).

Practical Protocols: Step-by-Step Approach

• Intake and assessment:

• • Detailed symptom inventory (fatigue, cold intolerance, cognitive fog, constipation, dry skin, hair thinning).
  • Review medication history for conversion-blocking agents.
  • Measure TSH, FT4, FT3, rT3, TPO/TgAb, fasting insulin/glucose, lipid panel, CRP, and stool analysis.

• Core interventions:
  • Nutritional strategies:

• • • Anti-inflammatory, gut-supportive plan emphasizing polyphenols, omega-3s, prebiotic fibers, and adequate protein.
    • Ensure micronutrients for deiodinase function: selenium, zinc, iron, iodine (cautiously, especially in autoimmunity), vitamin D, B vitamins (especially B2, B6, B12), and magnesium (Gereben et al., 2008).

• • Gut restoration:

• • • Remove: ultra-processed foods, alcohol excess, unnecessary NSAIDs.
    • Replace: digestive support where indicated (enzymes, bile support).
    • Reinoculate: targeted probiotics and prebiotics tailored from stool results (Bifidobacterium and Lactobacillus strains for SCFA support).
    • Repair: L-glutamine, N-acetyl-D-glucosamine, butyrate, omega-3s, and polyphenols to reduce permeability.

• • Stress regulation:

• • • Breathwork (paced respiration), mindfulness training, biofeedback for HRV, and graded exercise to reduce cortisol and improve vagal tone.

• • Chiropractic care and rehabilitation:

• • • Spinal adjustments to modulate autonomic balance and pain.
    • Myofascial release and mobility training for movement restoration.
    • Neuromuscular stabilization (core and cervical stabilizers), especially for patients with personal injuries.

• • Targeted thyroid therapy:

• • • If FT3 remains low with symptoms and elevated rT3, consider combination therapy with LT4 + LT3 under medical supervision.
    • Monitor heart rate, BP, bone health markers, and adjust gradually to avoid overtreatment (Bianco et al., 2019).

• • Insulin resistance management:

• • • Carb periodization, resistance training, sleep optimization, and possibly berberine, inositol, and GLP-1 therapies when appropriate under MD supervision.

• Follow-up cadence:

• • Reassess labs at 8–12 weeks after interventions.
  • Correlate improvements in symptoms, energy, sleep, HRV, gastrointestinal function, and exercise tolerance with lab changes.
  • Iterate: intensify gut protocols if dysbiosis persists; refine thyroid dosing cautiously.

The Benefits of a Healthy Diet and Chiropractic Care -Video

Why Patients With “Normal” Labs Still Feel Hypothyroid

• Tissue hypothyroidism:

• • The cellular availability of FT3 determines thyroid action. If conversion is impaired, tissues are hypothyroid despite “normal” TSH.
  • Elevated binding proteins (e.g., SHBG) or increased rT3 can reduce bioavailable FT3 (Weetman, 2013).

• Pituitary-thyroid mismatch:

• • Central (pituitary) variations and age-related changes can normalize TSH while peripheral tissues remain underpowered.

• Clinical take-home:

• • Track symptoms and functional outcomes alongside FT3/FT4 and rT3; don’t manage exclusively to TSH.

This is why we educate patients and providers. If therapy normalizes labs but the patient still feels unwell, consider conversion dynamics and the gut-stress axis rather than discontinuing treatment prematurely.

Integrating Internal Medicine Oversight: Safety and Precision

• Dr. Cardenas’ role:

• • Validates differential diagnoses (e.g., anemia, chronic infection, autoimmune overlap).
  • Screens for cardiovascular risk when considering LT3 addition, especially in older patients or those with arrhythmias.
  • Oversees medication reconciliation to avoid interactions that impair conversion or increase risk.
  • Manages referrals and interdisciplinary coordination for imaging, cardiology, endocrinology, or gastroenterology when needed.

• Benefit to patients:

• • Integrative care without sacrificing medical safety.
  • Therapy plans calibrated for complex comorbidities common in personal injury and chronic disease populations.

Clinical Observations From Our Practice

From my clinical experience documented across our resources (see dralexjimenez.com and my LinkedIn), several patterns are consistent:

• Patients with chronic musculoskeletal pain often present with low FT3, elevated cortisol, and gut dysbiosis. Pain and poor sleep act as continuous stressors, raising rT3 and suppressing conversion. Chiropractic adjustments and rehabilitation reduce pain, improve sleep, and accelerate recovery of thyroid function when combined with gut-focused nutrition and stress modulation.
• Individuals with insulin resistance typically show sluggish T4-to-T3 conversion. When we target IR with resistance training, meal timing, fiber and protein prioritization, and occasionally pharmacotherapy under Dr. Cardenas, we see normalization of FT3 and energy levels.
• Autoimmune thyroiditis (Hashimoto’s) cases improve when we address intestinal permeability, dietary triggers, micronutrient sufficiency, and stress. Antibody titers often decline, and symptom control improves even before medication changes.

These observations align with the literature on the gut-thyroid axis, stress physiology, and metabolic interference with deiodinases.

Why We Elevate FT3 Within Safe, Optimal Boundaries

• Physiological rationale:

• • FT3 governs mitochondrial respiration, cardiac inotropy, lipid metabolism, and neuronal function. Suboptimal FT3 is akin to low cellular “RPMs.”

• Clinical reasoning:

• • Patients at the low end of “normal” FT3 frequently have poor metabolic health and higher mortality risk metrics (Iervasi et al., 2003; Jabbar et al., 2017). Carefully optimizing FT3—without tipping into hyperthyroidism—restores function.

• Safety measures:

• • Gradual titration with symptom-guided endpoints.
  • Cardiac monitoring when indicated.
  • Bone health surveillance in long-term therapy.

Our approach follows evidence and prioritizes patient outcomes over rigid adherence to single-lab normalization.

Education and Systems Thinking: A System of Systems

Thyroid care cannot be siloed. The gut impacts the brain, the brain impacts the gut; the endocrine system thrives or falters with metabolic and autonomic inputs. Clinicians benefit from stepping back to view the body as a system of systems. At our clinic, we operationalize that view through interdisciplinary coordination: chiropractic modulation of autonomic tone; internal medicine governance for diagnostics and safety; functional medicine for lifestyle and biochemical targeting; and rehabilitation to restore resilient movement.

This systems approach allows us to solve the root problem rather than shuffle patients among specialties without integration.

Patient Journey: What to Expect

• Initial visit:

• • Comprehensive history, physical examination, and functional assessments.
  • Lab orders spanning thyroid, stress axis, metabolic markers, and gut analysis.

• Care plan:

• • Personalized nutrition, gut repair protocol, stress modulation, chiropractic and rehabilitative therapy, and medical oversight for thyroid and metabolic therapies.

• Follow-up:

• • Iterative adjustments based on symptom changes and lab trends.
  • Education and resources for self-care and lifestyle integration.

By aligning care processes with physiology and research, most patients experience measurable improvements in energy, cognition, sleep, body composition, and overall vitality.

Conclusion: Integrative Thyroid Optimization Is Achievable

The misconception that TSH alone defines thyroid health has led millions to remain symptomatic. By focusing on FT3, FT4, rT3, antibodies, and the gut-stress-metabolic axes, we uncover actionable root causes. With Dr. Cardenas’ medical direction and our integrative chiropractic-functional approach, we deploy safe, coordinated strategies that improve outcomes. Evidence supports optimizing FT3 within normal ranges to enhance cardiovascular and metabolic health. We educate, measure, and adapt—bringing modern, evidence-based care to everyday clinical practice.

For more insights and clinical cases, visit my resources:

• https://dralexjimenez.com/
• https://www.linkedin.com/in/dralexjimenez/

References

• Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association (Garber et al., 2012).
• Thyroid hormone transport and metabolism in the context of systemic illness (Fliers, Wiersinga, & Boelen, 2014).
• Thyroid hormone activation and inactivation by deiodinases (Gereben et al., 2008).
• Insights into deiodinase function and regulation (Bianco & Kim, 2006).
• Low T3 syndrome and cardiovascular outcomes (Iervasi et al., 2003).
• Thyroid function and all-cause mortality: meta-analyses and clinical implications (Jabbar et al., 2017).
• Thyroid hormone treatment: mechanisms, evidence, and patient-centered strategies (Bianco et al., 2019).
• The gut microbiome: role in endocrine and metabolic regulation (Gérard, 2016).
• Microbiome and estrogen metabolism: the estrobolome in health and disease (Plottel & Blaser, 2011).
• Insulin resistance and thyroid hormone interplay (Ghasemi et al., 2019).
• Thyroid function across aging: shifts in deiodinase activity and binding proteins (Gerritsen et al., 2020).
• TSH reference intervals and interpretation challenges (Surks et al., 2004).
• Thyroid autoimmunity and clinical management (Weetman, 2013).
• Autonomic modulation and musculoskeletal interventions: implications for HRV and endocrine function (Martínez-Rodríguez et al., 2021).

SEO Tags

thyroid health, free T3, free T4, TSH limitations, reverse T3, deiodinase enzymes, gut dysbiosis, insulin resistance, cortisol and thyroid, integrative chiropractic care, internal medicine oversight, functional medicine, hormone optimization, Hashimoto’s thyroiditis, nutraceuticals for thyroid, gut-thyroid axis, El Paso integrative clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr Maria Guadalupe Cardenas MD, Dr Alex Jimenez DC, evidence-based thyroid care, autonomic nervous system, HRV and hormones